Document is current

Article History

Received: 5 November 2024

Accepted: 11 November 2024

First Online: 2 December 2024

Declarations

:

: The Corresponding author (FSDP) and Michail Sorotos (MS) would like to disclose that the NESMOS Department with which they are affiliated, has received research funds from Motiva Establishment Labs in 2017, and from GC Aesthetics in 2018 and 2020. The NESMOS Department has also received mini-implants from Establishment Labs, GC Aesthetics and Sebbin for research purposes. FSDP was a paid consultant for BellaSeno GmbH from 2021 till 2023, he has received reimbursements for travel/lodging expenses from ICEAG in 2015 and SCHEER-WG in 2019, 2020 and 2021, and is a member of Notified Body 0373, part of the Superior Institute of Health, which carries out CE Mark certification activities for the Italian Ministry of Health for the year 2021. FSdP received a speaker fee from Establishment Labs in 2023 and 2024. MS received a speaker fee from Establishment Labs in 2024. They have no ownerships or investments to disclose. All other authors hereby certify, that to the best of their knowledge no financial support or benefits has been received, neither by themselves directly, nor by any member of their immediate family or any individual or entity with whom or with which they may have a significant relationship from any commercial source which is related directly or indirectly to the scientific work which is reported on in the article. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.

: This article does not contain research performed on human subjects or animals. Not applicable. For this type of study informed ethical review board approval consent was not required.

: For this type of study informed consent is not required.